Modified tripeptides

Modified tripeptides

Modified oxytocin-vasopressin di- or tri-peptides wherein an amide group is replaced by a group selected from -CH2NH-, -CH2O-, -CH2S-, -CH2SO-, -CH2SO2-, -CH2CH2- and -CH=CH- are described as well as methods for their manufacture, pharmaceutical compositions and methods for treatment, especially of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: REPINE, JOSEPH T, LUNNEY, ELIZABETH A, NICOLAIDES, ERNEST D, ROARK, W. HOWARD, TINNEY, FRANCIS J, DEJOHN, DANA E, KALTENBRONN, JAMES S
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
TECHNICAL SUBJECTS COVERED BY FORMER USPC
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ARTCOLLECTIONS [XRACs] AND DIGESTS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Modified oxytocin-vasopressin di- or tri-peptides wherein an amide group is replaced by a group selected from -CH2NH-, -CH2O-, -CH2S-, -CH2SO-, -CH2SO2-, -CH2CH2- and -CH=CH- are described as well as methods for their manufacture, pharmaceutical compositions and methods for treatment, especially of cognitive disorders, depression, morphine dependency and parkinsonism by adjunctive therapy.